Non-Interventional Study on the Tolerability and Efficacy of IVIG

Clinical trial NCT02303093 · COMPLETED

Trial details

NCT number: NCT02303093
Sponsor: Octapharma
Status: COMPLETED
Study type: OBSERVATIONAL

Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG

Start date: 2011-08-01
Primary completion: 2020-06-05
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.